Showing results (371-380 of 715) with videos related to
Sort By:
Pageof 72
Expert Review of Neurotherapeutics|April 8, 2011
Pre-operative intracranial meningioma embolizationJason A Ellis, Randy D'Amico, Michael B Sisti, et al.Clinical Immunology (Orlando, Fla.)|February 5, 2022
Longitudinal analysis of urinary proteins in lupus nephritis - A pilot studyEmil Carlsson, Alexandra Quist, Jennifer C Davies, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.Lupus|March 4, 2016
Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of careI N Bruce, M Urowitz, R van Vollenhoven, et al.Oncotarget|February 13, 2016
Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivoGeorg Karpel-Massler, Matei A Banu, Chang Shu, et al.Lupus Science & Medicine|January 25, 2022
Immune gene expression and functional networks in distinct lupus nephritis classesAlyssa C Gilmore, Hannah R Wilson, Thomas D Cairns, et al.Journal of Neuro-Oncology|July 20, 2007
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissueShailendra Joshi, Mei Wang, Joshua J Etu, et al.Arthritis and Rheumatism|February 13, 2013
Shortened telomere length in patients with systemic lupus erythematosusSahena Haque, Chadi Rakieh, Fiona Marriage, et al.Journal of Neuro-Oncology|September 8, 2014
Cationic surface charge enhances early regional deposition of liposomes after intracarotid injectionShailendra Joshi, Rajinder Singh-Moon, Mei Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastomaAllen Waziri, Brendan Killory, Alfred T Ogden, et al.Pageof 72